Table 3 Association between serum chloride and 90-day and 365-day all-cause mortality in COPD critically ill patients.
Model 1 | Model 2 | Model 3 | Model 4 | P | ||||
|---|---|---|---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | ||
90d-mortality | ||||||||
Serum Chloride (continuous) | 0.99 (0.97, 1.00) | 0.020 | 0.98 (0.97, 0.99) | 0.003 | 0.98 (0.97, 0.99) | < 0.001 | 0.96 (0.94, 0.98) | < 0.001 |
Serum Chloride (categorical) | ||||||||
Q1 | Ref | Ref | Ref | Ref | ||||
Q2 | 0.66 (0.53, 0.81) | < 0.001 | 0.65 (0.52, 0.80) | < 0.001 | 0.66 (0.53, 0.81) | < 0.001 | 0.64 (0.51, 0.80) | < 0.001 |
Q3 | 0.60 (0.49, 0.74) | < 0.001 | 0.59 (0.48, 0.73) | < 0.001 | 0.61 (0.49, 0.75) | < 0.001 | 0.60 (0.47, 0.77) | < 0.001 |
Q4 | 0.72 (0.59, 0.89) | 0.002 | 0.67 (0.54, 0.82) | < 0.001 | 0.64 (0.52, 0.78) | < 0.001 | 0.54 (0.41, 0.71) | < 0.001 |
P for trend | 0.001 | < 0.001 | < 0.001 | < 0.001 | ||||
365d-mortality | ||||||||
Serum Chloride (continuous) | 0.98 (0.97, 0.99) | < 0.001 | 0.97 (0.96, 0.98) | < 0.001 | 0.97 (0.96, 0.98) | < 0.001 | 0.96 (0.94, 0.97) | < 0.001 |
Serum Chloride (categorical) | ||||||||
Q1 | Ref | Ref | Ref | Ref | ||||
Q2 | 0.61 (0.51, 0.73) | < 0.001 | 0.60 (0.50, 0.72) | < 0.001 | 0.60 (0.51, 0 .72) | < 0.001 | 0.60 (0.49, 0.72) | < 0.001 |
Q3 | 0.60 (0.50, 0.71) | < 0.001 | 0.58 (0.49, 0.69) | < 0.001 | 0.60 (0.50, 0.72) | < 0.001 | 0.61 (0.50, 0.75) | < 0.001 |
Q4 | 0.64 (0.54, 0.76) | < 0.001 | 0.59 (0.50, 0.71) | < 0.001 | 0.57 (0.48, 0.68) | < 0.001 | 0.52 (0.42, 0.66) | < 0.001 |
P for trend | < 0.001 | < 0.001 | < 0.001 | < 0.001 | ||||